NEW YORK (Reuters) - Cynk Technologies, which was briefly worth billions of dollars last month, saw its shares fall below $1 on Monday, and traders say it is only a matter of time before the stock is ...

It is not often that penny stocks—and the pump-and-dump fraud schemes to which they are vulnerable—receive much attention beyond the blogs and chat rooms that cover the Wild West of over-the-counter ...

Tulip mania’s got nothing on Cynk Technology — the social-network wannabe that’s not only revenue-free but very nearly employee-free. Those operating impediments, however, couldn’t sink Cynk’s stock.

The U.S. Securities and Exchange Commission stepped in Friday morning and halted trading of the mysterious penny stock-turned-$6 billion company CYNK Technology. But while the feds investigate whether ...

Ordinarily, a money-losing company like Cynk Technology Corp. (OTC:CYNK) would languish on the over-the-counter stock market and attract little attention from either investors or the media. Cynk, ...

The financial world is agog at the story of Cynk Technology, which is a company that appears to have one employee, large losses, no turnover and no assets: yet a $4.5 billion stock market valuation.

Getting your Trinity Audio player ready... Cynk Technology Corp., the supposed operator of a social network that caught the attention of the financial world with its skyrocketing stock price, was ...

The SEC has issued a statement on the trading halt in shares of CYNK Technology. Earlier this morning, CYNK shares were halted for trade, though nothing official had been released by the SEC. Now, the ...

Penny-stock traders are hoping for clarification Friday as they await the Securities and Exchange Commission’s next directive in the curious case of Cynk Technology. The SEC suspended trading in Cynk ...

Since mid-June, a mysterious penny stock called CYNK Technology has surged an astonishing 25,000%. On Friday, in response to the meteoric rise in CYNK's share price, the SEC halted trading in the ...

Some of the people associated with CYNK, the mysterious social networking company that generated headlines last week when its stock surged 25,000% in just 16 trading days, have worked together before.

Natural killer cell therapy CYNK-101 was granted fast track designation by the FDA to treat HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with standard ...